Comparison of Piezoelectric and Conventional Surgery for Germectomy of the Lower Third Molar
Launched by AMERIGO GIUDICE · Jan 15, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different methods for removing lower third molars, commonly known as wisdom teeth. Researchers want to find out if using a piezoelectric technique, which uses sound waves to cut bone, leads to less swelling and discomfort compared to the traditional surgical method. This trial is especially focused on young patients aged 14 to 24 who have wisdom teeth that are not fully developed and need to be removed for various reasons, like preventing future dental issues.
If you or someone you know is between 14 and 24 years old and is in good health, they may be eligible to participate in this study. Participants will undergo the removal of both lower wisdom teeth and will be monitored for any differences in swelling and recovery between the two methods. It's important to note that the study is currently recruiting participants, and having clear dental images is a requirement to ensure the best possible outcome for the procedure. This trial could help improve how wisdom teeth are removed in the future!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients aged between 14 and 24 years, with both lower third molars in the developmental stage (with incompletely formed roots) and requiring extraction of both for prophylactic, therapeutic or strategic reasons
- • Good quality of radiographic investigations (CBCT)
- • Good health status
About Amerigo Giudice
Amerigo Giudice is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative studies. With a strong emphasis on ethical practices and regulatory compliance, the organization collaborates with leading researchers and institutions to conduct rigorous trials across various therapeutic areas. By fostering a culture of transparency and collaboration, Amerigo Giudice aims to accelerate the development of safe and effective treatments, ensuring that the needs of patients and the medical community are at the forefront of their initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Catanzaro, , Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported